News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Event
March 14, 2020
2020

SynBioBeta 2019

Event
March 14, 2020
2020

Discovery on Target 2020

News
March 12, 2020
2020

AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19

News
March 10, 2020
2020

AbCellera Named to Fast Company's Annual List of the World's Most Innovative Companies for 2020

News
February 24, 2020
2020

Invetx Announces $15 million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development

News
January 28, 2020
2020

AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program

News
October 31, 2019
2019

Dr. Michael Hayden joins AbCellera's Board of Directors

News
September 27, 2019
2019

AbCellera named one of Canada's Top Growing Companies

News
September 5, 2019
2019

AbCellera Appoints Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel

News
June 13, 2019
2019

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease